Blocking Cancer-Nerve Crosstalk for Treatment of Metastatic Bone Cancer Pain

Adv Mater. 2022 Apr;34(17):e2108653. doi: 10.1002/adma.202108653. Epub 2022 Mar 22.

Abstract

The tumor microenvironment is a complex milieu where neurons constitute an important non-neoplastic cell type. From "cancer neuroscience," the crosstalk between tumors and neurons favors the rapid growth of both, making the cancer-nerve interaction a reciprocally beneficial process. Thus, cancer-nerve crosstalk may provide new targets for therapeutic intervention against cancer and cancer-related symptoms. We proposed a nerve-cancer crosstalk blocking strategy for metastatic bone cancer pain treatment, achieved by Mg/Al layered-double-hydroxide nanoshells (Mg/Al-LDH) with AZ-23 loaded inside and alendronate decorated outside. The pain-causing H+ is rapidly eliminated by the LDH, with neurogenesis inhibited by the antagonist AZ-23. As positive feedback, the decreased pain reverses the nerve-to-cancer Ca2+ crosstalk-related cell cycle, dramatically inhibiting tumor growth. All experiments confirm the improved pain threshold and enhanced tumor inhibition. The study may inspire multidisciplinary researchers to focus on cancer-nerve crosstalk for treating cancer and accompanied neuropathic diseases.

Keywords: cancer-nerve crosstalk; layered-double-hydroxide nanoshells; metastatic bone tumors; pain sensitization.

MeSH terms

  • Bone Neoplasms* / drug therapy
  • Bone Neoplasms* / pathology
  • Cancer Pain* / drug therapy
  • Cancer Pain* / metabolism
  • Humans
  • Neurons / metabolism
  • Pain / metabolism
  • Tumor Microenvironment